192 related articles for article (PubMed ID: 36167373)
1. Economic evaluation of endovascular treatment for acute ischaemic stroke in Thailand.
Rattanavipapong W; Worakijthamrongchai T; Soboon B; Luankongsomchit V; Kongmuangpuk M; Isaranuwatchai W; Teerawattananon Y; Nilanont Y
BMJ Open; 2022 Sep; 12(9):e064403. PubMed ID: 36167373
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion.
Ye Z; Zhou T; Zhang M; Zhou J; Xie F; Hill MD; Smith EE; Busse JW; Zhang Y; Liu Y; Wang X; Ma Z; An Z
CMAJ Open; 2023; 11(3):E443-E450. PubMed ID: 37192770
[TBL] [Abstract][Full Text] [Related]
3. Is concurrent intravenous alteplase in patients undergoing endovascular treatment for large vessel occlusion stroke cost-effective even if the cost of alteplase is only US$1?
Ospel JM; McDonough R; Kunz WG; Goyal M
J Neurointerv Surg; 2022 Jun; 14(6):568-572. PubMed ID: 34187871
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of thrombectomy alone versus alteplase before thrombectomy in acute ischemic stroke: results from the DIRECT-MT.
Ma H; Zhou Y; Gao L; Liu P; Zhang L; Xing P; Li Z; Shen H; Zhang H; Zhang Y; Zhang X; Hua W; Zhang Y; Liu J; Yin C; Yang P
J Neurosurg; 2023 Sep; 139(3):678-686. PubMed ID: 36790013
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of endovascular treatment with or without intravenous thrombolysis in acute ischemic stroke.
Qureshi AI; Akinci Y; Huang W; Ishfaq MF; Hassan AE; Siddiq F; Gomez CR
J Neurosurg; 2023 Jan; 138(1):223-232. PubMed ID: 35901768
[TBL] [Abstract][Full Text] [Related]
6. Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective.
Ni W; Kunz WG; Goyal M; Ng YL; Tan K; De Silva DA
BMJ Open; 2020 Sep; 10(9):e036517. PubMed ID: 32948553
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke.
Nguyen CP; Lahr MM; van der Zee DJ; van Voorst H; Roos YB; Uyttenboogaart M; Buskens E
Eur Stroke J; 2023 Sep; 8(3):638-646. PubMed ID: 37641549
[TBL] [Abstract][Full Text] [Related]
8. Influence of intravenous alteplase on endovascular treatment decision-making in acute ischemic stroke due to primary medium-vessel occlusion: a case-based survey study.
Kappelhof M; Ospel J; Kashani N; Cimflova P; Singh N; Almekhlafi MA; Menon BK; Fiehler J; Chen M; Sakai N; Goyal M
J Neurointerv Surg; 2022 May; 14(5):439-43. PubMed ID: 34035152
[TBL] [Abstract][Full Text] [Related]
9. Endovascular thrombectomy and intravenous alteplase in patients with acute ischemic stroke due to large vessel occlusion: A clinical practice guideline.
Ye Z; Busse JW; Hill MD; Lindsay MP; Guyatt GH; Prasad K; Agarwal A; Beattie C; Beattie J; Dodd C; Heran MKS; Narayan S; Chartúir NN; O'Donnell M; Resmini I; Sacco S; Sylaja PN; Volders D; Wang X; Xie F; Zachrison KS; Zhang L; Zhong H; An Z; Smith EE
J Evid Based Med; 2022 Sep; 15(3):263-271. PubMed ID: 36123777
[TBL] [Abstract][Full Text] [Related]
10. Endovascular Thrombectomy with or without Bridging Thrombolysis in Acute Ischemic Stroke: A Cost-Effectiveness Analysis.
Morsi RZ; Zhang Y; Zhu M; Xie S; Carrión-Penagos J; Desai H; Tannous E; Kothari SA; Khamis A; Darzi AJ; Tarabichi A; Bastin R; Hneiny L; Thind S; Siegler JE; Coleman ER; Mendelson SJ; Mansour A; Prabhakaran S; Kass-Hout T
Neuroepidemiology; 2024; 58(1):47-56. PubMed ID: 38128500
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Endovascular Thrombectomy with and without Thrombolysis for Acute Large Artery Ischaemic Stroke at a Tertiary Stroke Centre.
Wee CK; McAuliffe W; Phatouros CC; Phillips TJ; Blacker D; Singh TP; Baker E; Hankey GJ
Cerebrovasc Dis Extra; 2017; 7(2):95-102. PubMed ID: 28463832
[TBL] [Abstract][Full Text] [Related]
12. Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal.
Jones ML; Holmes M
Health Technol Assess; 2009 Sep; 13 Suppl 2():15-21. PubMed ID: 19804685
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours.
Chen J; Liang X; Tong X; Han M; Ji L; Zhao S; Hu Z; Liu A
J Neurointerv Surg; 2023 Jan; 15(1):46-51. PubMed ID: 35074896
[TBL] [Abstract][Full Text] [Related]
15. Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials.
Wang X; Ye Z; Busse JW; Hill MD; Smith EE; Guyatt GH; Prasad K; Lindsay MP; Yang H; Zhang Y; Liu Y; Tang B; Wang X; Wang Y; Couban RJ; An Z
Stroke Vasc Neurol; 2022 Dec; 7(6):510-517. PubMed ID: 35725244
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke.
LeCouffe NE; Kappelhof M; Treurniet KM; Rinkel LA; Bruggeman AE; Berkhemer OA; Wolff L; van Voorst H; Tolhuisen ML; Dippel DWJ; van der Lugt A; van Es ACGM; Boiten J; Lycklama À Nijeholt GJ; Keizer K; Gons RAR; Yo LSF; van Oostenbrugge RJ; van Zwam WH; Roozenbeek B; van der Worp HB; Lo RTH; van den Wijngaard IR; de Ridder IR; Costalat V; Arquizan C; Lemmens R; Demeestere J; Hofmeijer J; Martens JM; Schonewille WJ; Vos JA; Uyttenboogaart M; Bokkers RPH; van Tuijl JH; Kortman H; Schreuder FHBM; Boogaarts HD; de Laat KF; van Dijk LC; den Hertog HM; van Hasselt BAAM; Brouwers PJAM; Bulut T; Remmers MJM; van Norden A; Imani F; Rozeman AD; Elgersma OEH; Desfontaines P; Brisbois D; Samson Y; Clarençon F; Krietemeijer GM; Postma AA; van Doormaal PJ; van den Berg R; van der Hoorn A; Beenen LFM; Nieboer D; Lingsma HF; Emmer BJ; Coutinho JM; Majoie CBLM; Roos YBWEM;
N Engl J Med; 2021 Nov; 385(20):1833-1844. PubMed ID: 34758251
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of remote robotic mechanical thrombectomy in acute ischemic stroke.
Sanmartin MX; Katz JM; Eusemann C; Boltyenkov AT; Sangha K; Bastani M; Turner R; Siddiqui AH; Mendes Pereira V; Hui FK; Mocco J; Sanelli PC
J Neurosurg; 2023 Sep; 139(3):721-731. PubMed ID: 36670531
[TBL] [Abstract][Full Text] [Related]
18. A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand.
Leelahavarong P; Chaikledkaew U; Hongeng S; Kasemsup V; Lubell Y; Teerawattananon Y
BMC Health Serv Res; 2010 Jul; 10():209. PubMed ID: 20633303
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of recombinant tissue-type plasminogen activator for acute ischaemic stroke with unknown time of onset: a Markov modelling analysis from the Chinese and US perspectives.
Zhao S; Cheng Y; Tong X; Han M; Ji L; Che Y; Hu W; Liu A
BMJ Open; 2022 Nov; 12(11):e065133. PubMed ID: 36375982
[TBL] [Abstract][Full Text] [Related]
20. Is Endovascular Therapy for Stroke Cost-Effective Globally? A Systematic Review of the Literature.
Waqas M; Gong AD; Levy BR; Dossani RH; Vakharia K; Cappuzzo JM; Becker A; Sonig A; Tutino VM; Almayman F; Davies JM; Snyder KV; Siddiqui AH; Levy EI
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105557. PubMed ID: 33556672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
